Does RASAGILINE Cause Neoplasm malignant? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Neoplasm malignant have been filed in association with RASAGILINE (Rasagiline). This represents 0.3% of all adverse event reports for RASAGILINE.
7
Reports of Neoplasm malignant with RASAGILINE
0.3%
of all RASAGILINE reports
1
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm malignant From RASAGILINE?
Of the 7 reports, 1 (14.3%) resulted in death, 4 (57.1%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RASAGILINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RASAGILINE Cause?
Fall (194)
Dyskinesia (169)
Tremor (161)
Hallucination (153)
Dizziness (134)
Gait disturbance (117)
Orthostatic hypotension (117)
Drug ineffective (104)
Condition aggravated (103)
Hallucination, visual (102)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which RASAGILINE Alternatives Have Lower Neoplasm malignant Risk?
RASAGILINE vs RASBURICASE
RASAGILINE vs RAVULIZUMAB
RASAGILINE vs RAVULIZUMAB-CWVZ
RASAGILINE vs REBAMIPIDE
RASAGILINE vs REBETOL